Skip to main navigation

Corporate
Healthcare Professionals
Patients

Health Policy Resources
Contact Us

About Axonics
- Who We Are
- Leadership
Investor Relations
Careers
Contact Us

News Releases

News Releases

Year

Sep 08, 2022

Axonics® Announces First Patient Implants in Canada With New Recharge-Free Sacral Neuromodulation System

Aug 18, 2022

Axonics® to Participate in September Investor Conferences

Aug 17, 2022

Axonics® Expands Sacral Neuromodulation Intellectual Property Portfolio

Aug 05, 2022

Axonics® Announces Closing of Public Stock Offering and Full Exercise of Underwriter’s Option to Purchase Additional Stock

Aug 02, 2022

Axonics® Announces Pricing of Public Offering of Common Stock

Aug 02, 2022

Axonics® Announces Proposed Public Offering of Common Stock

Aug 01, 2022

Axonics® Reports Second Quarter 2022 Financial Results

Jul 11, 2022

Axonics® to Report Second Quarter 2022 Financial Results on August 1

May 31, 2022

Axonics® Files PMA Supplement with FDA for Fourth Generation Rechargeable Neurostimulator

May 05, 2022

Axonics® Reports First Quarter 2022 Financial Results

Pagination

Current page 1
Page 2
Next page
Last page

Print Page Email Page Email Alerts RSS Feeds

Questions?

We are here to help answer any questions you may have about the Axonics System and Therapy.

CONTACT US

Corporate Healthcare Professionals Patients

About Axonics Investor Relations Careers Contact Us

Contact Us

© 2020-2022 Axonics, Inc.
Privacy Policy | Terms of Use | Important Safety Information | Sitemap